Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

More research is needed to understand if GLP-1 agonists affect hair health.

GLPLS and LPP are variants of lichen planus.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Ganoderma lucidum may help treat enlarged prostate in rats.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Weight-loss drugs are not linked to suicidal thoughts.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Medications for PCOS don't seem to raise heart disease risk.

New therapies and treatments for hair disorders, especially in curly hair, show promise.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Hair microscopy is a useful and affordable way to diagnose hair disorders.

The model and estimator can predict drug exposure in kidney transplant patients well.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.